Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,040 | 273 | 71.1% |
| Travel and Lodging | $3,644 | 16 | 25.8% |
| Debt forgiveness | $224.09 | 2 | 1.6% |
| Education | $140.24 | 1 | 1.0% |
| Honoraria | $62.45 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,317 | 21 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,845 | 18 | $0 (2020) |
| Abbott Laboratories | $1,808 | 31 | $0 (2024) |
| Medtronic, Inc. | $1,757 | 49 | $0 (2024) |
| ABIOMED | $1,398 | 8 | $0 (2024) |
| Boston Scientific Corporation | $845.73 | 24 | $0 (2024) |
| Amgen Inc. | $454.58 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $398.10 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $346.69 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $345.58 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,460 | 79 | Edwards Lifesciences Corporation ($1,470) |
| 2023 | $1,444 | 48 | Medtronic, Inc. ($351.93) |
| 2022 | $3,580 | 91 | Abbott Laboratories ($1,471) |
| 2021 | $1,320 | 29 | Medtronic, Inc. ($535.53) |
| 2020 | $1,904 | 19 | Medtronic Vascular, Inc. ($1,685) |
| 2019 | $938.13 | 17 | AstraZeneca Pharmaceuticals LP ($355.73) |
| 2018 | $448.18 | 9 | Medtronic Vascular, Inc. ($160.52) |
| 2017 | $16.58 | 1 | Boston Scientific Corporation ($16.58) |
All Payment Transactions
293 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Transcatheter Valve Systems | ||||||
| 12/10/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: Coronary | ||||||
| 12/07/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $493.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $156.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $68.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $59.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $411.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $153.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $49.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $5.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.20 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Renal Denervation System | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $154.63 | General |
| 11/14/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/06/2024 | Abbott Laboratories | NAVITOR (Device) | Food and Beverage | In-kind items and services | $80.40 | General |
| Category: Vascular | ||||||
| 10/25/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: Coronary | ||||||
| 10/23/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Not Applicable | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Ossur Americas, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.20 | General |
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $20.42 | General |
| Category: Coronary | ||||||
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,318 | 1,566 | $391,398 | $111,703 |
| 2022 | 19 | 1,044 | 1,163 | $282,989 | $86,850 |
| 2021 | 13 | 420 | 445 | $113,677 | $37,550 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 163 | 265 | $74,457 | $25,377 | 34.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 138 | 146 | $66,016 | $19,020 | 28.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 295 | 298 | $63,532 | $15,099 | 23.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 21 | 21 | $28,680 | $7,444 | 26.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 47 | 50 | $35,800 | $7,407 | 20.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 30 | 33 | $18,333 | $6,197 | 33.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 97 | $15,840 | $5,793 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $17,888 | $5,767 | 32.2% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 13 | 13 | $8,769 | $3,285 | 37.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 15 | 60 | $4,504 | $2,478 | 55.0% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 21 | 22 | $5,400 | $2,470 | 45.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 28 | 28 | $5,984 | $2,345 | 39.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 145 | 186 | $14,920 | $2,051 | 13.7% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 14 | 14 | $7,280 | $1,196 | 16.4% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 17 | 21 | $2,940 | $1,166 | 39.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 23 | 23 | $4,157 | $1,165 | 28.0% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 11 | 14 | $2,800 | $1,016 | 36.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 32 | 32 | $1,840 | $607.29 | 33.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 50 | 56 | $6,188 | $536.25 | 8.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 24 | 24 | $1,800 | $383.87 | 21.3% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 26 | 26 | $1,144 | $363.48 | 31.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 24 | 24 | $1,440 | $253.46 | 17.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 24 | 34 | $1,088 | $218.29 | 20.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 27 | 27 | $598.00 | $65.61 | 11.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 103 | 105 | $42,315 | $15,707 | 37.1% |
About Dr. Ashwin Murthy, MD
Dr. Ashwin Murthy, MD is a Interventional Cardiology healthcare provider based in Lakewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1720320914.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashwin Murthy, MD has received a total of $14,111 in payments from pharmaceutical and medical device companies, with $4,460 received in 2024. These payments were reported across 293 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($10,040).
As a Medicare-enrolled provider, Murthy has provided services to 2,782 Medicare beneficiaries, totaling 3,174 services with total Medicare billing of $236,103. Data is available for 3 years (2021–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Location Lakewood, CO
- Active Since 03/26/2013
- Last Updated 08/09/2021
- Taxonomy Code 207RI0011X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720320914
Products in Payments
- Resolute (Device) $1,804
- PASCAL (Device) $1,470
- Impella (Device) $1,398
- MITRACLIP (Device) $1,312
- CoreValve Evolut (Device) $551.43
- Repatha (Biological) $454.58
- COREVALVE EVOLUT R (Device) $374.94
- XARELTO (Drug) $325.01
- ELIQUIS (Drug) $278.18
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $268.03
- ONYX FRONTIER (Device) $260.83
- BRILINTA (Drug) $249.76
- SYMPLICITY G3 (Device) $219.87
- FFRct (Device) $209.26
- RESOLUTE ONYX (Device) $207.05
- CAMZYOS (Drug) $201.87
- LEQVIO (Drug) $198.66
- OPTIMIZER (Device) $192.72
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $179.37
- ONYX 18 (Device) $158.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Lakewood
Nima Aghili, Md, MD
Interventional Cardiology — Payments: $204,602
Peyman Naji, M.d, M.D
Interventional Cardiology — Payments: $33,119
Travis Desa, Md, MD
Interventional Cardiology — Payments: $10,652
Dr. Michael Wahl, M.d, M.D
Interventional Cardiology — Payments: $8,672